BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7382169)

  • 1. [Hypervitaminosis A in renal failure (author's transl)].
    Saito H; Takeda M; Kato M; Nakamura K; Shimbo T; Nakayama M; Higasa Y; Wakabayashi Y; Hara K; Sato T
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):299-305. PubMed ID: 7382169
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypervitaminosis A toxicity in regular hemodialysis patients.
    Ono K
    Trans Am Soc Artif Intern Organs; 1984; 30():40-3. PubMed ID: 6543480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin A metabolism in dialysis patients--are dialysis patients poisoned by vitamin A? (author's transl)].
    Kawaguchi S; Maeda K; Yamamoto A; Kobayshi K
    Nihon Jinzo Gakkai Shi; 1980 Sep; 22(9):1209-20. PubMed ID: 7193257
    [No Abstract]   [Full Text] [Related]  

  • 4. [The study of impaired reducing power in chronic renal failure patients with emphasis on red blood cells and lipoperoxide (author's transl)].
    Kawaguchi S; Maeda K; Tsutsui S; Kobayashi K
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):401-12. PubMed ID: 7401393
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coagulation and fibrinolysis alterations in renal failure (author's transl)].
    Rocha E; Sánchez Ibarrola A; Arrizabalaga B; Páramo JA; Purroy A
    Sangre (Barc); 1980; 25(5B):740-59. PubMed ID: 7008223
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical significance of hypervitaminosis A in hemodialysed patients, especially in relation to anemia.
    Ueno T
    Osaka City Med J; 1978; 24(2):195-207. PubMed ID: 756517
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vitamin A and lipids in serum during long term dialysis program].
    Mydlík M; Derzsiová K; Ahlers I; Hildebrand T; Takác M
    Z Urol Nephrol; 1977 May; 70(5):339-44. PubMed ID: 408996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of platelet kinetics in chronic renal failure (conservative and regular dialysis treatment) (author's transl)].
    Lusvarghi E; Curci G; Sacchi S; Baraldi P; Baraldi A; Cappelli G; Landini S; Malmusi G; Orlandini G; Savazzi AM; Vandelli L; Quaglino D
    Haematologica; 1979 Dec; 64(6):747-58. PubMed ID: 121088
    [No Abstract]   [Full Text] [Related]  

  • 9. [HDL-cholesterol in chronic renal failure and renal transplant (author's transl)].
    Masdeu S; Rubiés-Prat J; Nubiola AR; Ras MR; Masana L
    Med Clin (Barc); 1981 Oct; 77(7):280-3. PubMed ID: 7033690
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum iPTH concentration in chronic renal failure and its relationship to calcium metabolism (author's transl)].
    Asano Y; Kusano E; Marumo F; Torigai S; Kikawada R; Matsubayashi T; Sato S; Hirata S
    Nihon Jinzo Gakkai Shi; 1978 Jul; 20(7):747-57. PubMed ID: 722977
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of plasma renin activity in patients under chronic dialysis treatment (author's transl)].
    Kaneda H; Murata T; Matsumoto J; Haruyama T
    Nihon Naika Gakkai Zasshi; 1979 Mar; 68(3):276-84. PubMed ID: 399487
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in serum osmolality during hemodialysis of patients with chronic renal insufficiency (author's transl)].
    Loutocký A; Lachmanová J; Tomásek R; Horký K
    Cas Lek Cesk; 1977 Feb; 116(6):177-81. PubMed ID: 851974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Baclofen toxicity during intermittent renal dialysis (author's transl)].
    Seyfert S; Kraft D; Wagner K
    Nervenarzt; 1981 Oct; 52(10):616-7. PubMed ID: 7300979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Magnesemia in patients with renal insufficiency in the period of time proceding the hemodialysis therapy (author's transl)].
    Revúsová V; Gratzlová J; Reznicek J; Pribylincová V; Boroösvá E; Zvara V
    Cas Lek Cesk; 1976 Dec; 115(52):1608-11. PubMed ID: 1017007
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in intraerythrocytic 2,3-diphosphoglycerate occurring after dialysis in patients with chronic renal insufficiency (author's transl)].
    Lisý Z; Böswart J; Tomásek R
    Cas Lek Cesk; 1979 Feb; 118(7):201-4. PubMed ID: 445552
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in serum levels of triiodothyronine in dialyzed patients (author's transl)].
    Racek J; Slabý P; Holecek V
    Cas Lek Cesk; 1981 Jun; 120(24):733-5. PubMed ID: 7296619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Renin-angiotensin-aldosterone system in chronic renal failure. Part 2) change of renin-angiotensin-aldosterone system during hemodialysis (author's transl)].
    Fukuchi S; Nakajima K
    Nihon Jinzo Gakkai Shi; 1977 Oct; 19(10):809-14. PubMed ID: 604580
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum levels of vitamin A and retinol binding protein in chronic renal patients treated by continuous ambulatorial peritoneal dialysis.
    Vannucchi MT; Vannucchi H; Humphreys M
    Int J Vitam Nutr Res; 1992; 62(2):107-12. PubMed ID: 1517032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum transferrin levels in chronic renal failure. II. The relationship between anemia and nutrition in regular hemodialysis patients (author's transl)].
    Miura Y
    Nihon Jinzo Gakkai Shi; 1978 Mar; 20(3):243-53. PubMed ID: 671850
    [No Abstract]   [Full Text] [Related]  

  • 20. [Folates and vitamin B12 in chronic renal failure. A prospective study in haemodialysis patients (author's transl)].
    Hernández Nieto L; Brito Barroso ML; García Pérez J; Maceira Cruz B; Gonález García C
    Sangre (Barc); 1980; 25(5B):665-75. PubMed ID: 7466550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.